메뉴 건너뛰기




Volumn 17, Issue 1, 2007, Pages 23-29

Advances in Carnitine in Chronic Uremia

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; VITAMIN B COMPLEX;

EID: 33845765725     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2006.10.006     Document Type: Article
Times cited : (22)

References (56)
  • 1
    • 0003476675 scopus 로고    scopus 로고
    • Carnitine and carnitine esters in mitochondial metabolism and function
    • DeJong J., and Ferrari R. (Eds), Kluwer Academic Publishers, Norwell, Massachusetts
    • DiLisa F., Barbato R., Menabò R., et al. Carnitine and carnitine esters in mitochondial metabolism and function. In: DeJong J., and Ferrari R. (Eds). The Carnitine System (2005), Kluwer Academic Publishers, Norwell, Massachusetts 21-38
    • (2005) The Carnitine System , pp. 21-38
    • DiLisa, F.1    Barbato, R.2    Menabò, R.3
  • 3
    • 77953285722 scopus 로고    scopus 로고
    • Carnitine in renal failure
    • Kopple J., and Massry S. (Eds), Lippincott Williams & Wilkins, Baltimore, Maryland
    • Guarnieri G., Biolo G., Toigo G., et al. Carnitine in renal failure. In: Kopple J., and Massry S. (Eds). Nutritional Management of Renal Disease (2001), Lippincott Williams & Wilkins, Baltimore, Maryland 357-368
    • (2001) Nutritional Management of Renal Disease , pp. 357-368
    • Guarnieri, G.1    Biolo, G.2    Toigo, G.3
  • 4
    • 4444311812 scopus 로고    scopus 로고
    • Carnitine acyltransferases and their influence on CoA pools in health and disease
    • Ramsay R.R., and Zammit V.A. Carnitine acyltransferases and their influence on CoA pools in health and disease. Mol Aspects Med 25 (2004) 475-493
    • (2004) Mol Aspects Med , vol.25 , pp. 475-493
    • Ramsay, R.R.1    Zammit, V.A.2
  • 5
    • 10644253401 scopus 로고    scopus 로고
    • The role of the carnitine system in human metabolism
    • Foster D.W. The role of the carnitine system in human metabolism. Ann N Y Acad Sci 1033 (2004) 1-16
    • (2004) Ann N Y Acad Sci , vol.1033 , pp. 1-16
    • Foster, D.W.1
  • 6
    • 4444315751 scopus 로고    scopus 로고
    • Carnitine: A nutritional, biosynthetic, and functional perspective
    • Steiber A., Kerner J., and Hoppel C.L. Carnitine: A nutritional, biosynthetic, and functional perspective. Mol Aspects Med 25 (2004) 455-473
    • (2004) Mol Aspects Med , vol.25 , pp. 455-473
    • Steiber, A.1    Kerner, J.2    Hoppel, C.L.3
  • 7
    • 27744549045 scopus 로고    scopus 로고
    • Levocarnitine and dialysis: A review
    • Schreiber B. Levocarnitine and dialysis: A review. Nutr Clin Practice 20 (2005) 218-243
    • (2005) Nutr Clin Practice , vol.20 , pp. 218-243
    • Schreiber, B.1
  • 8
    • 23244446985 scopus 로고    scopus 로고
    • L-carnitine: New aspects of a known compound-A brief survey
    • Lohninger A., Pittner G., and Pittner F. L-carnitine: New aspects of a known compound-A brief survey. Monatshefte Chemie 136 (2005) 1255-1368
    • (2005) Monatshefte Chemie , vol.136 , pp. 1255-1368
    • Lohninger, A.1    Pittner, G.2    Pittner, F.3
  • 9
    • 23244441419 scopus 로고    scopus 로고
    • The role of carnitine acyltransferases in the maintenance of cell function
    • Zammit V.A., Price N.T., Jackson V.N., et al. The role of carnitine acyltransferases in the maintenance of cell function. Monatshefte Chemie 136 (2005) 1299-1309
    • (2005) Monatshefte Chemie , vol.136 , pp. 1299-1309
    • Zammit, V.A.1    Price, N.T.2    Jackson, V.N.3
  • 10
    • 0023626878 scopus 로고
    • Carnitine metabolism in chronic renal failure
    • Guarnieri G., Toigo G., Crapesi L., et al. Carnitine metabolism in chronic renal failure. Kidney Int 32 (1987) S116-S127
    • (1987) Kidney Int , vol.32
    • Guarnieri, G.1    Toigo, G.2    Crapesi, L.3
  • 11
    • 0024824287 scopus 로고
    • Metabolic effects of supplementation of L-carnitine in the dialysate of patients treated with acetate hemodialysis
    • Guarnieri G., Toigo G., Crapesi L., et al. Metabolic effects of supplementation of L-carnitine in the dialysate of patients treated with acetate hemodialysis. Kidney Int 36 (1989) S247-S255
    • (1989) Kidney Int , vol.36
    • Guarnieri, G.1    Toigo, G.2    Crapesi, L.3
  • 12
    • 0002902876 scopus 로고
    • L-carnitine administration to hemodialysis patients: Has its time come?
    • Golper T.A., and Ahmad S. L-carnitine administration to hemodialysis patients: Has its time come?. Semin Dial 5 (1992) 94-98
    • (1992) Semin Dial , vol.5 , pp. 94-98
    • Golper, T.A.1    Ahmad, S.2
  • 13
    • 0033830243 scopus 로고    scopus 로고
    • Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis
    • Evans A.M., Faull R., Fornasini G., et al. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin Pharmacol Ther 68 (2000) 238-249
    • (2000) Clin Pharmacol Ther , vol.68 , pp. 238-249
    • Evans, A.M.1    Faull, R.2    Fornasini, G.3
  • 14
    • 4644278071 scopus 로고    scopus 로고
    • Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease
    • Evans A.M., Faull R.J., Nation R.L., et al. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. Kidney Int 66 (2004) 1527-1534
    • (2004) Kidney Int , vol.66 , pp. 1527-1534
    • Evans, A.M.1    Faull, R.J.2    Nation, R.L.3
  • 15
    • 25144483298 scopus 로고    scopus 로고
    • Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease
    • Reuter S.E., Evans A.M., Faull R.J., et al. Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease. Ann Clin Biochem 42 (2005) 387-393
    • (2005) Ann Clin Biochem , vol.42 , pp. 387-393
    • Reuter, S.E.1    Evans, A.M.2    Faull, R.J.3
  • 16
    • 10644293209 scopus 로고    scopus 로고
    • Carnitine replacement in end-stage renal disease and hemodialysis
    • Calvani M., Benatti P., Mancinelli A., et al. Carnitine replacement in end-stage renal disease and hemodialysis. Ann N Y Acad Sci 1033 (2004) 52-66
    • (2004) Ann N Y Acad Sci , vol.1033 , pp. 52-66
    • Calvani, M.1    Benatti, P.2    Mancinelli, A.3
  • 17
    • 0036192012 scopus 로고    scopus 로고
    • Effects of L-carnitine supplementation in maintenance hemodialysis patients: A systematic review
    • Hurot J.M., Cucherat M., Haugh M., et al. Effects of L-carnitine supplementation in maintenance hemodialysis patients: A systematic review. J Am Soc Nephrol 13 (2002) 708-714
    • (2002) J Am Soc Nephrol , vol.13 , pp. 708-714
    • Hurot, J.M.1    Cucherat, M.2    Haugh, M.3
  • 19
    • 0035011124 scopus 로고    scopus 로고
    • Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients
    • Brass E.P., Adler S., Sietsema K.E., et al. Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients. Am J Kidney Dis 37 (2001) 1018-1028
    • (2001) Am J Kidney Dis , vol.37 , pp. 1018-1028
    • Brass, E.P.1    Adler, S.2    Sietsema, K.E.3
  • 20
    • 0025152162 scopus 로고
    • Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects
    • Ahmad S., Robertson H.T., Golper T.A., et al. Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kideny Int 38 (1990) 912-918
    • (1990) Kideny Int , vol.38 , pp. 912-918
    • Ahmad, S.1    Robertson, H.T.2    Golper, T.A.3
  • 21
    • 0024268248 scopus 로고
    • Interaction of carnitine with insulin-stimulated glucose metabolism in humans
    • Ferrannini E., Buzzigoli G., Bevilacqua S., et al. Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol 255 (1988) E946-E952
    • (1988) Am J Physiol , vol.255
    • Ferrannini, E.1    Buzzigoli, G.2    Bevilacqua, S.3
  • 22
    • 2442766181 scopus 로고    scopus 로고
    • The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure
    • Gunal A.I., Celiker H., Donder E., et al. The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure. J Nephrol 12 (1999) 38-40
    • (1999) J Nephrol , vol.12 , pp. 38-40
    • Gunal, A.I.1    Celiker, H.2    Donder, E.3
  • 23
    • 0036788293 scopus 로고    scopus 로고
    • Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes
    • Kelley D.E., He J., Menshikova E.V., et al. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51 (2002) 2944-2950
    • (2002) Diabetes , vol.51 , pp. 2944-2950
    • Kelley, D.E.1    He, J.2    Menshikova, E.V.3
  • 24
    • 0034058841 scopus 로고    scopus 로고
    • Reduced synthesis of muscle proteins in chronic renal failure
    • Adey D., Kumar R., McCarthy J.T., et al. Reduced synthesis of muscle proteins in chronic renal failure. Am J Physiol Endocrinol Metab 278 (2000) E219-E225
    • (2000) Am J Physiol Endocrinol Metab , vol.278
    • Adey, D.1    Kumar, R.2    McCarthy, J.T.3
  • 25
    • 0023835418 scopus 로고
    • Chronic renal failure, parathyroid hormone and fatty acids oxidation in skeletal muscle
    • Smogorzewski M., Piskorska G., Borum P.R., et al. Chronic renal failure, parathyroid hormone and fatty acids oxidation in skeletal muscle. Kidney Int 33 (1988) 555-560
    • (1988) Kidney Int , vol.33 , pp. 555-560
    • Smogorzewski, M.1    Piskorska, G.2    Borum, P.R.3
  • 26
    • 11844251989 scopus 로고    scopus 로고
    • Inflammation and carnitine in hemodialysis patients
    • Pertosa G., Grandaliano G., Simone S., et al. Inflammation and carnitine in hemodialysis patients. J Ren Nutr 15 (2005) 8-12
    • (2005) J Ren Nutr , vol.15 , pp. 8-12
    • Pertosa, G.1    Grandaliano, G.2    Simone, S.3
  • 27
    • 11844262893 scopus 로고    scopus 로고
    • L-carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients
    • Savica V., Santoro D., Mazzaglia G., et al. L-carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients. J Ren Nutr 15 (2005) 225-230
    • (2005) J Ren Nutr , vol.15 , pp. 225-230
    • Savica, V.1    Santoro, D.2    Mazzaglia, G.3
  • 28
    • 10644296222 scopus 로고    scopus 로고
    • Carnitines and its congeners: A metabolic pathway to the regulation of immune response and inflammation
    • Famularo G., DeSimone C., Trinchieri V., et al. Carnitines and its congeners: A metabolic pathway to the regulation of immune response and inflammation. Ann N Y Acad Sci 1033 (2004) 132-138
    • (2004) Ann N Y Acad Sci , vol.1033 , pp. 132-138
    • Famularo, G.1    DeSimone, C.2    Trinchieri, V.3
  • 29
    • 0027405265 scopus 로고
    • High dose L-carnitine improves immunologic and metabolic parameters in AIDS patients
    • DeSimone C., Tzantzoglu S., Famularo G., et al. High dose L-carnitine improves immunologic and metabolic parameters in AIDS patients. Immunopharmacol Immunotoxicol 15 (1993) 1-12
    • (1993) Immunopharmacol Immunotoxicol , vol.15 , pp. 1-12
    • DeSimone, C.1    Tzantzoglu, S.2    Famularo, G.3
  • 30
    • 0030028606 scopus 로고    scopus 로고
    • The expression of TNF alpha by human muscle: Relationship to insulin resistance
    • Saghizadeh M., Ong J.M., Garvey W.T., et al. The expression of TNF alpha by human muscle: Relationship to insulin resistance. J Clin Invest 97 (1996) 1111-1116
    • (1996) J Clin Invest , vol.97 , pp. 1111-1116
    • Saghizadeh, M.1    Ong, J.M.2    Garvey, W.T.3
  • 31
    • 23244468294 scopus 로고    scopus 로고
    • Carnitine and fatty acid oxidation in sepsis
    • Eaton S., and Pierro A. Carnitine and fatty acid oxidation in sepsis. Monats Chemie 136 (2005) 1483-1492
    • (2005) Monats Chemie , vol.136 , pp. 1483-1492
    • Eaton, S.1    Pierro, A.2
  • 32
    • 0041703026 scopus 로고    scopus 로고
    • L-carnitine: A nutritional modulator of glucocorticoid receptor functions
    • Alesci S., DeMartino M.U., Mirani M., et al. L-carnitine: A nutritional modulator of glucocorticoid receptor functions. FASEB J 17 (2003) 1553-1555
    • (2003) FASEB J , vol.17 , pp. 1553-1555
    • Alesci, S.1    DeMartino, M.U.2    Mirani, M.3
  • 33
    • 10644296911 scopus 로고    scopus 로고
    • Modulatory effects of L-carnitine on glucocorticoid receptor activity
    • Manoli I., De Martino M.U., Kino T., et al. Modulatory effects of L-carnitine on glucocorticoid receptor activity. Ann N Y Acad Sci 1033 (2004) 147-157
    • (2004) Ann N Y Acad Sci , vol.1033 , pp. 147-157
    • Manoli, I.1    De Martino, M.U.2    Kino, T.3
  • 34
    • 0028887004 scopus 로고
    • Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock
    • Winter B.K., Fiskum G., Gallo L.L., et al. Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock. Br J Cancer 72 (1995) 1173-1179
    • (1995) Br J Cancer , vol.72 , pp. 1173-1179
    • Winter, B.K.1    Fiskum, G.2    Gallo, L.L.3
  • 35
    • 0034936833 scopus 로고    scopus 로고
    • Effect of L-carnitine supplementation in hemodialysis patients
    • Vesela E., Racek J., Trefil L., et al. Effect of L-carnitine supplementation in hemodialysis patients. Nephron 88 (2001) 218-223
    • (2001) Nephron , vol.88 , pp. 218-223
    • Vesela, E.1    Racek, J.2    Trefil, L.3
  • 36
    • 0037219409 scopus 로고    scopus 로고
    • Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?
    • Evans J.L., Goldfine I.D., Maddux B.A., et al. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?. Diabetes 52 (2003) 1-8
    • (2003) Diabetes , vol.52 , pp. 1-8
    • Evans, J.L.1    Goldfine, I.D.2    Maddux, B.A.3
  • 37
    • 0037225664 scopus 로고    scopus 로고
    • Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress
    • Pignatelli P., Lenti L., Sanguigni V., et al. Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress. Am J Physiol Heart Circ Physiol 284 (2003) H41-H48
    • (2003) Am J Physiol Heart Circ Physiol , vol.284
    • Pignatelli, P.1    Lenti, L.2    Sanguigni, V.3
  • 38
    • 2042460866 scopus 로고    scopus 로고
    • L-carnitine ameliorates oxidative damage due to chronic renal failure in rats
    • Sener G., Paskaloglu K., Satiroglu H., et al. L-carnitine ameliorates oxidative damage due to chronic renal failure in rats. J Cardiovasc Pharmacol 43 (2004) 698-705
    • (2004) J Cardiovasc Pharmacol , vol.43 , pp. 698-705
    • Sener, G.1    Paskaloglu, K.2    Satiroglu, H.3
  • 39
    • 28844438030 scopus 로고    scopus 로고
    • Antioxidant effect of L-carnitine and its short chain esters: Relevance for the protection from oxidative stress related cardiovascular damage
    • Calò L.A., Pagnin E., Davis P.A., et al. Antioxidant effect of L-carnitine and its short chain esters: Relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol 107 (2006) 54-60
    • (2006) Int J Cardiol , vol.107 , pp. 54-60
    • Calò, L.A.1    Pagnin, E.2    Davis, P.A.3
  • 40
    • 0031764132 scopus 로고    scopus 로고
    • Body composition and long-term levo-carnitine supplementation
    • Trovato G.M., Iannetti E., Murgo A.M., et al. Body composition and long-term levo-carnitine supplementation. Clin Ter 149 (1998) 209-214
    • (1998) Clin Ter , vol.149 , pp. 209-214
    • Trovato, G.M.1    Iannetti, E.2    Murgo, A.M.3
  • 41
    • 0035752994 scopus 로고    scopus 로고
    • Dietary L-carnitine suppresses mitochondrial branched-chain keto acid dehydrogenase activity and enhances protein accretion and carcass characteristics of swine
    • Owen K.Q., Jit H., Maxwell C.V., et al. Dietary L-carnitine suppresses mitochondrial branched-chain keto acid dehydrogenase activity and enhances protein accretion and carcass characteristics of swine. J Anim Sci 79 (2001) 3104-3112
    • (2001) J Anim Sci , vol.79 , pp. 3104-3112
    • Owen, K.Q.1    Jit, H.2    Maxwell, C.V.3
  • 42
    • 9344242965 scopus 로고    scopus 로고
    • Atlantic salmon (Salmo salar) fed L-carnitine exhibit altered intermediary metabolism and reduced tissue lipid, but no change in growth rate
    • Ji H., Bradley T.M., and Tremblay G.C. Atlantic salmon (Salmo salar) fed L-carnitine exhibit altered intermediary metabolism and reduced tissue lipid, but no change in growth rate. J Nutr 126 (1996) 1937-1950
    • (1996) J Nutr , vol.126 , pp. 1937-1950
    • Ji, H.1    Bradley, T.M.2    Tremblay, G.C.3
  • 43
    • 4944239832 scopus 로고    scopus 로고
    • Cancer-related anorexia-cachexia syndrome and oxidative stress: An innovative approach beyond current treatment
    • Mantovani G., Madeddu C., Maccio A., et al. Cancer-related anorexia-cachexia syndrome and oxidative stress: An innovative approach beyond current treatment. Cancer Epidemiol Biomarkers Prev 13 (2004) 1651-1659
    • (2004) Cancer Epidemiol Biomarkers Prev , vol.13 , pp. 1651-1659
    • Mantovani, G.1    Madeddu, C.2    Maccio, A.3
  • 44
    • 0028153264 scopus 로고
    • Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers
    • Giovenali P., Fenocchio D., Montanari G., et al. Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers. Kidney Int 46 (1994) 1616-1619
    • (1994) Kidney Int , vol.46 , pp. 1616-1619
    • Giovenali, P.1    Fenocchio, D.2    Montanari, G.3
  • 45
    • 0025152162 scopus 로고
    • Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects
    • Ahmad S., Robertson H.T., Golper T.A., et al. Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 38 (1990) 912-918
    • (1990) Kidney Int , vol.38 , pp. 912-918
    • Ahmad, S.1    Robertson, H.T.2    Golper, T.A.3
  • 46
    • 0022887274 scopus 로고
    • Effect of L-carnitine on post-stress metabolism in surgical patients
    • Heller W., Musil H.E., Gaebel G., et al. Effect of L-carnitine on post-stress metabolism in surgical patients. Infusionsther Klin Ernahr 13 (1986) 268-276
    • (1986) Infusionsther Klin Ernahr , vol.13 , pp. 268-276
    • Heller, W.1    Musil, H.E.2    Gaebel, G.3
  • 47
    • 0024593903 scopus 로고
    • Clinical relevance of L-carnitine-supplemented total parenteral nutrition in postoperative trauma: Metabolic effects of continuous or acute carnitine administration with special reference to fat oxidation and nitrogen utilization
    • Pichard C., Roulet M., Schutz Y., et al. Clinical relevance of L-carnitine-supplemented total parenteral nutrition in postoperative trauma: Metabolic effects of continuous or acute carnitine administration with special reference to fat oxidation and nitrogen utilization. Am J Clin Nutr 49 (1989) 283-289
    • (1989) Am J Clin Nutr , vol.49 , pp. 283-289
    • Pichard, C.1    Roulet, M.2    Schutz, Y.3
  • 48
    • 3342936592 scopus 로고    scopus 로고
    • The effect of L-carnitine on fat oxidation, protein turnover, and body composition in slightly overweight subjects
    • Wutzke K.D., and Lorenz H. The effect of L-carnitine on fat oxidation, protein turnover, and body composition in slightly overweight subjects. Metabolism 53 (2004) 1002-1006
    • (2004) Metabolism , vol.53 , pp. 1002-1006
    • Wutzke, K.D.1    Lorenz, H.2
  • 50
    • 0028850504 scopus 로고
    • Primary and secondary carnitine deficiency syndromes
    • Pons R., and DeVivo D.C. Primary and secondary carnitine deficiency syndromes. J Child Neurol 10 suppl 2 (1995) S8-S24
    • (1995) J Child Neurol , vol.10 , Issue.SUPPL. 2
    • Pons, R.1    DeVivo, D.C.2
  • 51
    • 20844457939 scopus 로고    scopus 로고
    • Carnitine therapy is associated with decreased hospital utilization among hemodialysis patients
    • Kazmi W.H., Obrador G.T., Sternberg M., et al. Carnitine therapy is associated with decreased hospital utilization among hemodialysis patients. Am J Nephrol 25 (2005) 106-115
    • (2005) Am J Nephrol , vol.25 , pp. 106-115
    • Kazmi, W.H.1    Obrador, G.T.2    Sternberg, M.3
  • 52
    • 30744455082 scopus 로고    scopus 로고
    • Carnitine treatment improved quality-of-life measure in a sample of midwestern hemodialysis patients
    • Steiber A.L., Davis A.T., Spry L., et al. Carnitine treatment improved quality-of-life measure in a sample of midwestern hemodialysis patients. JPEN J Parenter Enteral Nutr 30 (2006) 10-15
    • (2006) JPEN J Parenter Enteral Nutr , vol.30 , pp. 10-15
    • Steiber, A.L.1    Davis, A.T.2    Spry, L.3
  • 53
    • 1242342233 scopus 로고    scopus 로고
    • Serum carnitine concentrations correlated to clinical outcome parameters in chronic hemodialysis patients
    • Steiber A.L., Weatherspoon L.J., Spry L., et al. Serum carnitine concentrations correlated to clinical outcome parameters in chronic hemodialysis patients. Clin Nutr 23 (2004) 27-34
    • (2004) Clin Nutr , vol.23 , pp. 27-34
    • Steiber, A.L.1    Weatherspoon, L.J.2    Spry, L.3
  • 54
    • 3042648665 scopus 로고    scopus 로고
    • Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease
    • Vaux E.C., Taylor D.J., Altmann P., et al. Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease. Nephron Clin Pract 97 (2004) c41-c48
    • (2004) Nephron Clin Pract , vol.97
    • Vaux, E.C.1    Taylor, D.J.2    Altmann, P.3
  • 55
    • 0037249525 scopus 로고    scopus 로고
    • Nutritional effects of carnitine supplementation in hemodialysis patients
    • Chazot C., Blanc C., Hurot J.M., et al. Nutritional effects of carnitine supplementation in hemodialysis patients. Clin Nephrol 59 (2003) 24-30
    • (2003) Clin Nephrol , vol.59 , pp. 24-30
    • Chazot, C.1    Blanc, C.2    Hurot, J.M.3
  • 56
    • 23844556828 scopus 로고    scopus 로고
    • Common misconceptions about levocarnitine and dialysis
    • Schreiber B. Common misconceptions about levocarnitine and dialysis. Semin Dial 18 (2005) 349-351
    • (2005) Semin Dial , vol.18 , pp. 349-351
    • Schreiber, B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.